CRISPR Therapeutics (CRSP) Debt to Equity Ratio: 0.4732

CRISPR Therapeutics AG (CRSP)

48.56 -3.22 (-6.21%) USD | NASDAQ | Nov 05, 16:00

48.86 +0.30 (+0.62%) After-Hours: 07:06

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to 2016. Start Trial.

Date	Value
September 30, 2026	0.4732
June 30, 2026	0.4487
March 31, 2026	0.4341
December 31, 2025	0.1076
September 30, 2025	0.1101
June 30, 2025	0.1259
March 31, 2025	0.1199
December 31, 2024	0.1158
September 30, 2024	0.1173
June 30, 2024	0.1168
March 31, 2024	0.1127
December 31, 2023	0.1267
September 30, 2023	0.1398
June 30, 2023	0.135
March 31, 2023	0.1295
December 31, 2022	0.1301
September 30, 2022	0.1239
June 30, 2022	0.1159
March 31, 2022	0.1065
December 31, 2021	0.0938
September 30, 2021	0.0817
June 30, 2021	0.0734

Date	Value
March 31, 2021	0.034
December 31, 2020	0.0369
September 30, 2020	0.0366
June 30, 2020	0.0551
March 31, 2020	0.058
December 31, 2019	0.0559
September 30, 2019	0.0703
June 30, 2019	0.1144
March 31, 2019	0.0964
December 31, 2018	0.00
September 30, 2018	0.00
June 30, 2018	0.00
March 31, 2018	0.00
December 31, 2017	0.00
September 30, 2017	0.00
June 30, 2017	0.00
March 31, 2017	0.00
December 31, 2016	0.00
September 30, 2016	0.00
June 30, 2016	0.00
March 31, 2016	0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks